Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Zix Corp Board Member Bought Shares at $4.50 a Piece, Should You?

Zix Corp board memberE. Michael Dailey, Director at Zix Corporation (NASDAQ:ZIXI)’s Board, acquired last Tuesday, Oct. 8th, 1,000 shares from the company. He paid $4.50 per share, totaling $4,500. After the reported transaction, he owns 10,000 shares of common stock, valued at $45,100.

Zix Corporation (NASDAQ:ZIXI)

Dailey started a position in the company 6 months ago, and has been purchasing stock every month ever since. However, he is not the only insider betting on Zix Corp. L Maribess Miller, also a Board Director, bought 4,000 shares this year; and J Mark Bonney, an extra 5,000. All of them bought in the company this year.

On the other hand, Richard Spurr, Chairman and CEO, sold more than 300,000 shares this year. Similar is F James Brashear‘s (Vice President of the General Counsil) case, who got rid of approximately 40,000 shares. Finally, W Michael English, CFO, sold about 5,000 extra shares during 2013.

Zix Corporation has been quite commented on lately, mainly because it has been one of the most shorted stocks of the Russell 3000 over the last few months. However, what was interesting was that some of the insiders previously mentioned were taking the other side of the trade, buying stock from short traders.

Back to Dailey, his acquisition seems to be a bet on this quarter’s performance. Financial results will be announced on Oct.22nd, and the purchase might be anticipating this. The purchase also follows some price target raises, like the one made by Imperial Capital, which lifted its target price from $5,50 to $6,00. Considering that the stock now trades at $4.51, the upside potential is substantial.  In addition, its valuation at 32.7 times its earnings, at a 28% discount to its industry’s average, makes it an even more attractive purchase.

Disclosure: Javier Hasse holds no position in any stocks mentioned

Recommended Reading:

Blackberry Co-Founder Mike Lazaridis Ups Stake to 8% in Bid for Buyout

CEO John Hart is Bullish on PICO Holdings

Rockwell Collins Insider Trading Activity Heats Up

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!